SCHEMBL3763655

SCHEMBL3763655

CCN(C)C(=O)c1cccc(B(O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.49
TDP1 Q9NUW8 1/20 0.49
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
PDK2 Q15119 1/20 0.42
LPL P06858 2/20 0.41
LIPG Q9Y5X9 2/20 0.41
TSHR P16473 2/20 0.40
HSD17B1 P14061 2/20 0.40
HSD17B2 P37059 2/20 0.40
LMNA P02545 1/20 0.40
ENPP2 Q13822 4/20 0.40
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CDK4 P11802 1/20 0.37
CCND1 P24385 1/20 0.37
MGLL Q99685 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1771787 0.85 HPGD (0.63) HPGDTDP1LPLLIPGTSHR
SCHEMBL29951715 0.85 HPGD (0.63) HPGDTDP1LPLLIPGTSHR
SCHEMBL29902315 0.83 ERN1 (0.48) HPGDMEN1KMT2AENPP2ALDH1A1
SCHEMBL177412 0.83 ERN1 (0.48) HPGDMEN1KMT2AENPP2ALDH1A1
SCHEMBL12538380 0.82 KMT2A (0.75) HPGDMEN1KMT2ATSHRHSD17B1
SCHEMBL490705 0.80 LPL (0.44) HPGDPDK2LPLLIPGALDH1A1
SCHEMBL11913144 0.80 HPGD (0.74) HPGDTDP1MEN1KMT2APDK2
SCHEMBL15535059 0.79 TP53 (0.49) HPGDTDP1LPLLIPGTSHR
SCHEMBL17119847 0.78 HSD17B1 (0.57) HPGDTDP1MEN1KMT2APDK2
SCHEMBL224885 0.77 ENPP2 (0.46) HPGDMEN1KMT2ATSHRHSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-10266532-B2 Tricyclic modulators of TNF signaling ABBVIE INC. (US) 2019-04-23 US disclosed
US-20180179198-A1 TRICYCLIC MODULATORS OF TNF SIGNALING ABBVIE INC. 2018-06-28 US disclosed
US-9856253-B2 Tricyclic modulators of TNF signaling ABBVIE, INC. (US) 2018-01-02 US disclosed
US-20160304517-A1 TRICYCLIC MODULATORS OF TNF SIGNALING ABBVIE INC. 2016-10-20 US disclosed
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304517-A1 TRICYCLIC MODULATORS OF TNF SIGNALING TNF, TNFRSF1A, CD40 HPGD 261/4885TDP1 3127/4885MEN1 2587/4885
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA HPGD 3366/4885TDP1 494/4885MEN1 2762/4885
US-10266532-B2 Tricyclic modulators of TNF signaling TNF, TNFRSF1A, CD40 HPGD 261/4885TDP1 3127/4885MEN1 2587/4885
US-20180179198-A1 TRICYCLIC MODULATORS OF TNF SIGNALING TNF, TNFRSF1A, CD40 HPGD 261/4885TDP1 3127/4885MEN1 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.